Europe vs Luxembourg: Proportion of the target population who received the final dose of
Europe
40.0%
in 2024
Luxembourg
79.0%
in 2024
Europe rank
21st
Luxembourg rank
24th
Proportion of the target population who received the final dose of over time
- Europe
- Luxembourg
How they compare
Luxembourg currently reports 79.0% against 40.0% in Europe, a difference of 39.0%.
That makes Luxembourg's figure about 2.0 times Europe's.
The two have swapped places 1 time across 15 shared years of data; in 2010 it was Europe ahead.
Europe ranks 21st and Luxembourg ranks 24th of 35 groups.
Across the 2 decades both report, Europe averaged higher in 1 and Luxembourg in 1.
Head to head by decade
| Decade | Europe | Luxembourg | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 29.9% | 25.5% | 4.4% | Europe |
| 2020s | 36.8% | 75.2% | 38.4% | Luxembourg |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received the final dose of, Europe or Luxembourg?
- Luxembourg, at 79.0% against 40.0% in Europe as of 2024.
- What is the difference in proportion of the target population who received the final dose of between Europe and Luxembourg?
- 39.0%, with Luxembourg ahead.
- How many years of comparable data are there for Europe and Luxembourg?
- 15 years are reported by both, from 2010 to 2024.
- How do Europe and Luxembourg rank globally for proportion of the target population who received the final dose of?
- Europe ranks 21st and Luxembourg ranks 24th of 35 groups.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.